Fragment CJC-1295 + Ipamorelin Blend 12mg
CAS: 66004-57-7 / 446262-90-4 / 170851-70-4
Fragment CJC-1295 + Ipamorelin Blend 12mg is a premium research-grade peptide formulation combining Fragment 6 mg (CAS 66004-57-7), CJC-1295 no DAC 3 mg (CAS 446262-90-4), and Ipamorelin 3 mg (CAS 170851-70-4). Manufactured using Solid-Phase Peptide Synthesis (SPPS) and validated through HPLC and Mass Spectrometry, this triple-peptide blend provides ≥99% purity and exceptional molecular stability for advanced endocrine signaling and growth hormone pathway research.
$215.00
Research Use Only
Triple-Peptide Research Compound Overview
Fragment CJC-1295 + Ipamorelin Blend 12mg from Biopeptides is a laboratory-grade peptide formulation developed for advanced endocrine and molecular signaling research.
This blend integrates three peptides with complementary signaling mechanisms that allow researchers to study growth hormone–related pathways and receptor interactions.
By combining Fragment 6 mg, CJC-1295 no DAC, and Ipamorelin in a single compound, laboratories can analyze coordinated peptide signaling in controlled experimental environments.
Scientific Background of the Peptide Blend
CJC-1295 no DAC is a truncated analog of growth hormone–releasing hormone (GHRH) used in research to stimulate growth hormone release pathways.
Ipamorelin is a selective ghrelin receptor agonist that activates growth hormone secretagogue receptors (GHS-R), supporting studies of endocrine signaling and receptor interactions.
Fragment 6 mg provides structural stability to the peptide blend and enhances molecular integrity in laboratory conditions.
Together, these peptides provide researchers with a robust experimental tool for studying growth hormone dynamics and cellular signaling.
Mechanistic Research Perspective
- Activation of growth hormone–releasing hormone receptor signaling
- Selective stimulation of ghrelin receptor (GHS-R) pathways
- Investigation of coordinated peptide–receptor signaling networks
- Analysis of downstream protein synthesis pathways
- Evaluation of metabolic and cellular growth signaling responses
Primary Research Applications
Growth Hormone Pathway Studies: Used in experimental models to analyze endocrine signaling mechanisms that regulate growth hormone release and receptor interactions.
Cellular Regeneration Research: Supports studies exploring cellular proliferation, regeneration pathways, and tissue growth models in controlled laboratory environments.
Protein Synthesis and Metabolic Research: Applied in biochemical experiments examining protein synthesis pathways and metabolic regulation processes.
Receptor Binding Studies: Allows researchers to investigate peptide binding affinity and receptor activation across endocrine signaling systems.
Biochemical Assays and Molecular Experiments: Suitable for in vitro and ex vivo assays studying peptide signaling, cellular metabolism, and hormonal pathway modulation.
Molecular Characteristics
- Molecular Type: Triple synthetic peptide research blend
- Structure: Linear synthetic peptides
- CAS Identifiers: 66004-57-7, 446262-90-4, 170851-70-4
- Form: Lyophilized peptide powder blend
- Molecular Weight: Sequence-dependent
- Stability: High when stored under recommended laboratory conditions
Stability Profile and Storage Recommendations
- Supplied as a lyophilized peptide blend for long-term stability
- Recommended storage temperature: −20°C
- Protect from humidity and direct light exposure
- Avoid repeated freeze–thaw cycles
- Reconstituted solutions remain stable for approximately 24–48 hours under refrigeration
Solubility and Reconstitution Options
- Sterile bacteriostatic water
- Buffered aqueous solutions
- Sterile saline solutions
- Phosphate-buffered saline (PBS)
- Analytical-grade laboratory buffers
Technical Specifications
product Name
Fragment CJC-1295 + Ipamorelin Blend 12mg
brand
Biopeptides
cas
66004-57-7 / 446262-90-4 / 170851-70-4
purity
≥99% (HPLC validated)
unit Size
12 mg blend
form
Lyophilized powder
synthesis
Solid-Phase Peptide Synthesis (SPPS)
analytical
HPLC, Mass Spectrometry
molecular Structure
Linear synthetic peptides
stability
High when stored appropriately
Analytical Validation and Quality Assurance
- High-Performance Liquid Chromatography (HPLC) purity verification
- Mass Spectrometry molecular identity confirmation
- Batch-to-batch consistency validation
- Quality control testing for research reliability
- Analytical documentation available for laboratory records
Regulatory and Compliance Statement
Fragment CJC-1295 + Ipamorelin Blend 12mg is supplied strictly for laboratory research and scientific investigation. It is not approved for human consumption, veterinary use, pharmaceutical treatment, cosmetic formulation, or nutritional applications. Certificates of Analysis (COA) and Material Safety Data Sheets (MSDS) are available upon request to support institutional research documentation and compliance requirements.
Frequently Asked Questions
The blend is used in laboratory studies to investigate growth hormone pathways, protein synthesis, receptor signaling, and cellular regeneration mechanisms.
Fragment 6 mg – 66004-57-7, CJC-1295 no DAC – 446262-90-4, and Ipamorelin – 170851-70-4.
Yes. Biopeptides supplies this research peptide blend to laboratories across Germany, France, Italy, Spain, the Netherlands, and other EU regions.
Store the lyophilized peptide blend at −20°C and protect it from moisture and light exposure.
No. The product is intended strictly for laboratory research and scientific investigation.
Purity ≥99% is verified through HPLC analysis and mass spectrometry validation.
Biopeptides provides high-purity peptides, validated analytical documentation, and reliable supply for laboratories across Europe.